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Abstract
Background: Globally, the provision of equitable outcomes for women with breast cancer is a priority for governments.
However, there is growing evidence that a socioeconomic status (SES) gradient exists in outcomes across the breast
cancer continuum – namely incidence, diagnosis, treatment, survival and mortality. This systematic review describes this
evidence and, because of the importance of place in defining SES, findings are limited to the Australian experience.
Methods: An on-line search of PubMed and the Web of Science identified 44 studies published since 1995 which
examined the influence of SES along the continuum. The critique of studies included the study design, the types and
scales of SES variable measured, and the results in terms of direction and significance of the relationships found. To aid
in the interpretation of results, the findings were discussed in the context of a systems dynamic feedback diagram.
Results: We found 67 findings which reported 107 relationships between SES within outcomes along the continuum.
Results suggest no differences in the participation in screening by SES. Higher incidence was reported in women with
higher SES whereas a negative association was reported between SES and diagnosis. Associations with treatment choice
were specific to the treatment choice undertaken. Some evidence was found towards greater survival for women with
higher SES, however, the evidence for a SES relationship with mortality was less conclusive.
Conclusions: In a universal health system such as that in Australia, evidence of an SES gradient exists, however, the
strength and direction of this relationship varies along the continuum. This is a complex relationship and the
heterogeneity in study design, the SES indicator selected and its representative scale further complicates our
understanding of its influence. More complex multilevel studies are needed to better understand these relationships,
the interactions between predictors and to reduce biases introduced by methodological issues.
Keywords: Breast cancer continuum, Socioeconomic status, Feedback diagram, Australia
Introduction
Addressing the delivery of equitable health services for
the identification and treatment of cancer is a priority
for high income nations. In Australia, like many other
industrialised countries, breast cancer is the most com-
mon cancer affecting women [1]. A considerable amount
of resources are directed to address issues relating to
breast cancer along a continuum; i.e. the prevention, inci-
dence/risk, detection/diagnosis, treatment, survivorship,
survival and mortality [2]. However, there is growing evi-
dence of socioeconomic status (SES) gradients along the
stages of the breast cancer continuum [3–7]. The personal
impacts such as reduced quality of life and premature
deaths; societal impacts such as lost productivity; direct
and indirect health care costs of these disparities are sub-
stantial and need to be addressed.
Past reviews [5, 8] have highlighted methodological is-
sues which need to be considered to interpret the litera-
ture. The definition and measurement of SES is variable
between studies, however, SES is usually measured
through the socioeconomic triad, a mixture of single or
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composite indicators of employment, income and educa-
tion. These indicators have been found to have varying
associations depending on the type of cancer investi-
gated [9]. The scale at which these SES indicators are
collected has been found to influence these relationships.
SES data collected through surveys from individuals rep-
resent what are seen as compositional factors which ei-
ther promote or impede an individual’s health [10, 11].
For example, individuals reporting higher levels of edu-
cation [12] and income [13] have been found to have
higher incidence of breast cancer but a lower risk of
mortality. Where individual level data is not available,
area level SES measures collected from national surveys
or statistics have been used to represent two different
perspectives. One is to mimic, at an aggregated level, the
compositional individual level SES factors. Several
studies have found mixed findings as to how well these
area based statistics reflect individual circumstances
[14–17]. The second has been to embody the contextual
factors in which the individual resides [11], providing
additional information on living circumstances not cap-
tured by individual level variables [14]. These represent
differences in the physical environment, service provision,
as well as political and cultural characteristics which, inde-
pendent of personal circumstances, can influence health
behaviour and health status [2, 10, 18]. Recent reviews
have shown modest positive associations between the SES
of women’s residential area and breast cancer incidence
and screening but not mortality [4, 19]. However, meth-
odological differences relating to the scale of analysis used
and the type of SES indicator used have led to mixed find-
ings. For example, SES derived in smaller geographic units
compared to larger units has produced stronger relation-
ships in breast cancer survival [20] and incidence [21].
While the choice of indicator used and how it was defined
(single versus a composite indicator) have also impacted
the direction and magnitude of associations with survival
[22]. Where individual and area level SES data are avail-
able, several studies have undertaken investigations into
each characteristics’ effects, reporting a higher incidence
[23] and survival [24] from breast cancer in individuals
with higher levels of education or woman living in areas
of higher SES. To further evaluate the interactive effects
between individual and area level characteristics, multi-
level analysis has been used to disentangle the compos-
itional and contextual level influences for specific points
along the continuum. Several studies have reported a posi-
tive relationship between area level SES and incidence of
breast cancer [23, 25] while others report no association
[26, 27] citing individual SES as the major determinant
[27]. These analyses overcome several methodological lim-
itations present in looking at individual and area level SES
associations independently, namely, individual and eco-
logical fallacies and the Simpsons Paradox [28, 29].
Differences in the way SES is conceptualised, operatio-
nalised and analysed make comparisons between studies,
and coming to a consensus, difficult. However, these
must be taken into account so that the evidence base
can inform future research in these areas and govern-
ment policy. The aim of this study was to conduct a sys-
tematic review of literature to gather a weight of
evidence to determine the strength and direction of the
SES relationships across the breast cancer continuum.
Given that the concept of place is fundamental to under-
standing these relationships, we will restrict this review
to the Australian experience. This removes issues which
relate to studies based in different countries where there
are differences in the delivery of health services (univer-
sal versus private) and differences in the racial and eth-
nic structure of the population. Furthermore, by limiting
these studies to one geographic area, we can investigate
the effect of methodological issues on the relationships
and highlight any gaps in our understanding. In our re-
view we also restrict the definition of the breast cancer
continuum to incidence, detection, diagnosis, treatment,
survival and mortality. This allows us to focus on spe-
cific areas of outcomes and care. To tie the evidence
base across the continuum together we discuss the
findings through a simple systems dynamics feedback
diagram to provide a deeper understanding of the inter-
acting processes involved in incidence, detection, diag-
nosis, treatment and their effect on the outcomes of
survival and mortality. Gathering evidence at each stage,
determining the direction of significant trends, highlight-
ing evidence gaps for researchers, and understanding po-
tential feedbacks between and within the stages will help
to guide delivery of care and improve equity in outcomes
which remains a considerable challenge for policy
makers.
Methods
Search strategy
A list of search terms and keywords was developed and
refined to reflect a focus on the socioeconomic inequal-
ities across the breast cancer continuum among Austra-
lian women. Search terms lists were comprehensive and
inclusive, combined under the following headings: socio-
economic status, breast cancer and Australia. Search
terms were combined as follows:
1. Socio-economic status: e.g. SES, socio-economic,
socioeconomic, disadvantage, deprivation, income,
poverty, education, and employment; AND.
2. Breast cancer; AND.
3. Australia
The search was conducted at the end of July 2016 and
included PubMed and the Web of Science databases.
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Studies were included if they met the inclusion criteria
(described below). Unpublished work or published pro-
tocols without results were not included in the search.
Grey literature were not included in the review as not all
are indexed in scientific databases, however the relevant
government reports we could access were included in
the discussion. Finally, reference lists of identified arti-
cles were searched for additional relevant studies.
Study inclusion criteria
Types of participants
Australian female adults were the primary interest group
for this review; therefore studies of adult (aged 18+
years) female members of the general Australian popula-
tion were included.
Types of studies
Studies that examined the influence of SES (predictor)
on breast cancer (outcome) were included. SES could be
measured at the individual level (such as income or edu-
cation), at an area level (such as indicators of socioeco-
nomic status) or a combination of both. Studies of any
design were included such as secondary analysis of
population cancer registries, cross sectional retrospective
telephone surveys and other cohort studies.
Types of outcomes
From the selected studies we extracted evidence of the
types of findings which related to whether individual,
area, individual and area or multilevel analyses were
used and the significance of the relationships found
(positive, negative, non-significant or non-reported) of
SES gradients across the breast cancer continuum. This
methodology took into account the hierarchical nature
of the studies undertaken. Here, a study could poten-
tially have multiple types of findings using a variety of
individual and area level SES indicators and then report
numerous significant results of varying directions. Direc-
tion of significance was determined using higher socio-
economic position/least disadvantage as the reference
position. Therefore a positive relationship described
when a higher socioeconomic position was associated
with a higher incidence, higher likelihood of screening
or treatment, or greater survival.
Study exclusion criteria
To limit the focus to socioeconomic inequalities in the
general Australian adult population, studies that exam-
ined specific subgroups of the population such as Indi-
genous groups, children, individual case studies, people
in specific workplaces, or males were excluded. We
recognise that Indigenous women are a specific sub-
group of the population who are more likely to be lower
SES and experience poorer health outcomes. However,
given the complex interaction of personal, social, and
cultural factors affecting Indigenous women, and the
generalisability of findings, the studies addressing this
subgroup specifically were excluded from this review.
We limited our search to incidence, detection,
diagnosis, treatment, survival and mortality along the
breast cancer continuum. Studies that focused on the
behavioural risk factors of cancer such as diet and life-
style were excluded, as were those focused on the psy-
chosocial predictors, such as knowledge and attitudes,
towards cancer related behaviours or treatment. Studies
retrieved in the search that controlled for socioeconomic
factors as a covariate within their analysis but did not in-
clude it as an independent variable were also excluded.
Studies were limited to those published in English in
the last 20 years (1995 onwards), to ensure that the
findings of this review are relevant to the current health-
care context in Australia. One reviewer screened titles
against inclusion criteria for eligible articles, then two
reviewers screened abstracts and full text against the in-
clusion criteria with the final decision for inclusion made
by the first author (Fig. 1). A total of 44 papers were
identified through the search terms and from the refer-
ence lists of the studies collected.
Study quality assessment
We have assessed the body of evidence in relation to a
socioeconomic gradient in breast cancer across the con-
tinuum in Australian women. Some of the protocols for
assessing the quality of evidence are directed more to-
wards biomedical literature reviews (e.g. PRIMSA [30])
or clinical intervention (e.g. EPHPP [31]) which are not
appropriate for this review. The National Health and
Medical Research Council of Australia suggests five key
components for rating the ‘body of evidence’: the evi-
dence base, consistency of results, clinical impact, gener-
alisability of results, and applicability of results [32]. The
depth of the evidence base and consistency of its results
will form the basis of the quality assessment for this re-
view as these provide a picture of the internal validity of
the study data that will support the development of
policy. The other components of generalisability and ap-
plication to the Australian Healthcare context are not
really applicable here given this review is limited to
studies of Australian women, and therefore highly gener-
alisable and relevant to the target population. As part of
this review we provide comment on the quantity of evi-
dence for each stage across the continuum, that is the
number of studies and consistency of findings, and the
type of analysis undertaken in order to control for bias,
for example where univariate or multivariate analysis
was conducted. Relevant details were extracted from the
papers as part of the data extraction process, checked by
two reviewers and discrepancies resolved through
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discussion. Interpretation of the study quality was inte-
grated into the description of results and agreed to by all
authors. The majority (81%) of studies analysed popula-
tion based datasets of state or the whole Australian popu-
lation meaning that sample sizes were large and results
representative of the Australian population more gener-
ally. When the evidence was from cross sectional studies,
such as telephone surveys, the number of such studies
was articulated within the stage of the continuum. While
the quality of these studies could be deemed inferior to
population studies of larger samples, a trade-off exists be-
cause these studies provide valuable information about in-
dividual level SES, which is not usually collected in larger
population studies. Therefore, the study findings were not
weighted, but their results discussed within the body of
evidence for each stage along the continuum.
Data extraction strategy
Using a standardised Excel spreadsheet, one reviewer ex-
tracted data from papers including details of the study
population, study design, dataset analysed i.e. name of
the cancer or screening registry, used, stage across the
continuum, types of socioeconomic variables used at indi-
vidual and area levels and the scale at which the socioeco-
nomic variable was measured (individual, area, individual
and area, multilevel), statistical analysis, results and sum-
mary of findings. A second reviewer checked all data ex-
tracted, and the few discrepancies were resolved through
discussion. Given the heterogeneity in measurement of
SES, cancer outcomes and statistical analysis conducted,
meta-analysis was not possible. Instead the data synthe-
sised using frequency counts and described as a narrative
of findings.
Results
Overview
A total of 44 studies were included in this review.
Around a third of the studies were conducted in cohorts
from the New South Wales Cancer Registry. Seven
studies were from Western Australia and an additional
Fig. 1 Quorum statement flow diagram: Studies examining the influence of SES across the breast cancer continuum in Australian women
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seven studies analysed national datasets. From these 44
studies, 67 findings were extracted describing the impact
of SES across the continuum – incidence, diagnosis,
treatment, survival and mortality. Twelve findings (18%)
measured SES using individual level indicators thereby
highlighting compositional factors only, 31 (46%) mea-
sured SES with area level indicators highlighting a mix
of either compositional or contextual factors. Twenty-
one findings (31%) measured SES at individual and area
levels separately while three studies (4%) conducted
multilevel analysis. From these types of findings we
found a total of 51 individual level and 56 area based
SES indicators were used to quantify 107 relationships
between SES and outcomes along the continuum. To
quantify individual level SES, private health insurance
membership (n = 21, 41%) was most commonly used,
followed by level of education (n = 12, 24%), employ-
ment status (n = 12, 24%) and income (n = 6, 12%).
Across the continuum, individual level associations were
dominated by non-significant results particularly for em-
ployment and education status. However, there was a
weak positive association between private health insur-
ance membership and higher income and more positive
breast cancer outcomes (results not shown). For area
level SES, the most commonly used indicator (n = 42,
76% of area level studies) was the Index of Relative So-
cioeconomic Disadvantage (IRSD). The index relates to
the degree of area based social disadvantage based on
low levels of income and education and high unemploy-
ment [33]. This composite indicator is provided nation-
ally by the Australian Bureau of Statistics under their
Socio-Economic Indexes for Areas indicator program.
Income, education and employment information as sep-
arate single indicators were less frequently used. The
scale of area based analysis varied from fine through to
coarse levels. In terms of size and how many times used,
these varied by population from lowest to highest: the
Collector District (CD) (n = 15, 25%), postcode (n = 11,
20%), Local Government Area (LGA) (n = 11, 20%),
Statistical Local Area (SLA) (n = 10, 18%). Eight findings
(15%) were from an area which was not defined and one
used a municipality boundary.
At an aggregated level, the directions of relationships
between SES and outcomes in the continuum were simi-
lar but this depended on how the research question was
phrased and its effect within each stage of the con-
tinuum. A more detailed investigation at each stage is
provided in the next sections.
Screening
Fifteen findings described the impact of SES on breast
cancer screening (Table 1). The majority of studies were
telephone interviews or surveys which were cross sec-
tional in nature. Given these study design characteristics,
individual factors of SES such as education, income, em-
ployment and private health insurance and its impact on
attendance at screening were mainly investigated. From
these 15 findings, 32 SES relationships were identified
(Table 1), half the relationships showed non-significant
relationships between SES and screening, but this was
dependent on what specific type of screening participa-
tion was investigated. Therefore we have described the
results separately as those that have never participated
in screening, recent participation and overdue screening.
Several studies reported on combinations of these
situations.
Never screened
Three findings produced eight relationships between in-
dividual SES and the likelihood of never having had a
mammogram. The weight of evidence, four relation-
ships, was suggestive of a non-significant relationship
between never screened and education and private in-
surance status [34], and, income and employment [35].
Negative relationships were also shown, with women
who had lower education levels [36], without private
health insurance [35] and who resided in more disadvan-
taged areas [36] being more likely to never have had a
mammogram. Conversely, those with higher individual
income (> $40,000) [34] were more likely to never attend
screening.
Recent screening
Six findings described the relationship between individ-
ual level indicators of SES and attending recent screen-
ing with the weight of evidence, nine relationships,
suggesting non-significance. The majority of studies fo-
cussed on employment [37–40] and education [37, 38, 41]
as indicators of SES. There was limited evidence found for
positive associations between recent screenings and higher
income [42] and having private insurance [39]. A similar
number of relationships were found for a negative associ-
ation between recent screenings and higher educated
women [39, 40]. In one study, the positive associations
found between the two indicators were reported to be
non-significant [38]. No area or multilevel studies were
undertaken.
Overdue
Five findings examined overdue screening, again with
mixed results. One study reported that higher education
status and income level (≥$40,000) as well as having pri-
vate health insurance were positively associated with
overdue screening [34]. Whereas negative associations
were reported for indicators of lower education [36],
having no private health insurance and a low income
(less than $20,000) [35]. One area level study found
women residing in more disadvantaged areas had greater
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Table 1 The types of findings and number and direction of significance of SES relationships across the breast cancer continuum
Types of findings Significance
Stage Individual Area Individual and area Multilevel Total Positive Negative NS^ NR#
SCREENING: TOTAL 11 2 2 15 6 10 16
Screening - Never 2 1 3 1 3 4
Individual 2 1 2 4
Area - Not defined 1 1
Screening - Recent 6 6 2 2 9
Individual 6 2 2 9
Screening - Overdue 3 1 1 5 3 4 3
Individual 3 3 3 2
Postcode 1 1
Area - Not defined 1 1
Screening - access to services 1 1 1
CD 1 1
INCIDENCE: TOTAL 5 5 5 1
CD 1 2
LGA 3 2 1
SLA 1 1
DIAGNOSIS: TOTAL 5 4 1 10 2 8 4
Stage of diagnosis 5 1 1 7 7 3
Individual 1 1
CD 2 1 2 2
Postcode 1 1
LGA 1 1
SLA 1 1 2
Diagnostic procedure 1 1 1 1
Individual 1
Area - Not defined 1 1
Diagnostic results 2 2 1 1
Postcode 2 1 1
TREATMENT CHOICE: TOTAL 1 6 11 18 15 10 3 3
Provider characteristics 2 2 2 2
Individual 2
Postcode 2 2
Non-surgical Treatment 1 1 2 2 1
Individual 1
Postcode 1 1 2
No Surgery 1 1 1 1
Individual 1
Area - Not defined 1 1
Surgery - Breast Conserving 1 2 3 5
Individual 2
CD 1 1
Postcode 1 1
Area - Not defined 1 1
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likelihood of being overdue in screening [36]. Non-
significant relationships were also reported for employ-
ment status [35, 43] and area based disadvantage after
adjusting for Indigenous and ethnic status at the post-
code scale [44].
Access to services
We found only one study [45] which reported that
women living in disadvantaged areas (measured at the
fine area level scale) had greater access to mammog-
raphy facilities than their advantaged counterparts. How-
ever, the magnitude of the difference was not tested for
significance.
Incidence
Five area-based findings examined the relationship of
SES (the majority using IRSD) and incidence of breast
cancer using state based cancer registries. Four utilised
the same cancer registry (New South Wales Cancer
Registry) and reported higher incidence of cancer for
women who lived in high SES areas when compared to
low SES areas [46–49]. This was apparent in major city
populations [46, 47], in inner regional areas [46] and
using two different area indicators of SES [49]. This
positive relationship also held across different scales of
analysis, from CD to SLA at the area level (Table 1).
One study, however, found an increased risk of meta-
static breast cancer was associated with living in areas of
Table 1 The types of findings and number and direction of significance of SES relationships across the breast cancer continuum
(Continued)
Types of findings Significance
Stage Individual Area Individual and area Multilevel Total Positive Negative NS^ NR#
Surgery - Mastectomy 2 2 4 6
Individual 2
CD 1 1
Postcode 1 1
Municipality 1 1
Area - Not defined 1 1
Surgery - Reconstructive 1 3 4 8
Individual 1 5
CD 1 1
Postcode 1 1
Area - Not defined 1 1
Post-treatment Surgery 1 1 1
CD 1 1
Treatment Intensity before death 1 1 1 1
Individual 1
CD 1 1
SURVIVAL: TOTAL 6 2 1 9 7 5
Individual 2 1
CD 2 1 3
LGA 2 2
SLA 2 1 1 3 1
MORTALITY: TOTAL 7 2 1 10 2 6 5
Individual 1 1 1
CD 1 1
LGA 5 3 2
SLA 1 1 1 1 2
Area - Not defined 1 1
GRAND TOTAL 12 31 21 3 67 37 35 32 3
Note: NS^ Non-significant finding reported by authors, NR# Findings not reported by authors
Lyle et al. International Journal for Equity in Health  (2017) 16:182 Page 7 of 15
lower SES [50]. While data was not shown, difference in
incidence by SES measurement type was slightly greater
for quintiles defined by the IRSD in comparison to the
unemployment rate [49].
Diagnosis
Ten findings highlighted the individual and area level re-
lationships between SES and diagnosis of breast cancer.
Overall, the weight of evidence was towards a negative
relationship but this varied within three classifications:
stage, procedures and results.
Stage
Seven findings found a negative association between SES
and the stage of diagnosis. The majority were area based
studies where women in living in low SES areas were
more likely to be diagnosed with large, advanced staged
(distant) tumours [51, 52] compared to those in higher
SES areas, who were more likely to be diagnosed with
smaller, less advanced staged (localised and regional) tu-
mours [49, 53]. However, non-significance was found be-
tween SES and advanced disease stage at the area level
[49]. Controlling for the effect of individual SES charac-
teristics (occupation), a multilevel study [54] showed
that individual level employment type (blue collar in
reference to professionals) and women who lived in the
most disadvantaged areas were more likely to be diag-
nosed with advanced breast cancer. These findings were
consistent across different scales of area level analysis
(Table 1). One study reported a non-significant rela-
tionship between individual level education (after ad-
justment) and area based disadvantage in distant
reoccurrence [49].
Diagnostic procedure
One finding reported the significance of individual and
area based differences in diagnostic procedures by SES.
Women living in low SES areas (scale of area was not
defined) were twice as likely to receive open biopsy for a
diagnostic procedure as opposed to fine needle aspir-
ation (which was more likely in higher SES areas) and
core biopsy [55]. No trend was found when comparing
health insurance status.
Diagnostic results
Two findings showed mixed results between pathologic
test results to identify early invasive cancers and area
(postcode) level SES. Significance was dependent on
whether the variable analysed was in nominal or ordinal
forms. A triple negative result was less common for
oestrogen, progesterone and HER2 receptors in women
residing in higher SES areas (nominal) but was insignifi-
cant as an ordinal variable [56]. Bilateral synchronous le-
sions were less common in women residing in lower SES
areas (ordinal) but were non-significant as nominal vari-
ables [56].
Treatment choice
Eleven findings described SES in relation to different
types of treatment received for breast cancer. The majority
of studies [56–62] utilised finer area scales of analysis
(CD, postcode) (Table 1) and the IRSD as the indicator of
SES. The weight of evidence leaned slightly towards a
positive association, but significance of these findings dif-
fered across the eight areas of treatment classified by the
treatment literature (Table 1).
Provider characteristics
Two findings investigated individual and area level indica-
tors of SES and provider characteristics in the treatment
of early invasive breast cancers [56]. Disadvantaged
women had greater odds of being treated in inner regional
and remote centres. This interaction between SES and re-
moteness highlighted that they were 20% less likely to be
treated by more experienced high annual case load sur-
geons. Women living in disadvantaged areas had lower
odds (around 20%) of being referred for clinical surveil-
lance (asymptomatic referrals). The significance of these
relationships with insurance status was not reported.
Non-surgical treatments
Women living in the highest socioeconomic areas with
early invasive cancers were more likely to receive ovarian
ablation [56] and post-operative radiotherapy following
breast conserving surgery [59] when compared to those
living in the lowest SES areas. The significance of the re-
lationship with insurance status and ovarian ablation
was not reported [56].
No surgery
No surgery was the most common outcome for women
without private health insurance or those living in low
SES areas for early breast cancer [55].
Surgery – breast conserving
Breast conserving surgery was the most likely procedure
for those with private health insurance [55, 63] and
those living in high SES areas [55, 59, 63]. This result
did not vary across the individual and finer area levels of
SES indicators analysed.
Surgery – mastectomy
All findings investigating mastectomy showed that this
was the most likely procedure for women without pri-
vate health insurance [55, 63] and living in low SES areas
[59, 64]. This relationship was consistent across individual
and area level indicators of SES, differences in area scales
and variations in indicators definitions. Here, education
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[64] and a composite indicator of average education, em-
ployment and income [59] were used instead of the IRSD.
Surgery – reconstructive
Reconstructive surgery following mastectomy was more
likely for higher educated women [65] or those with pri-
vate health insurance [55, 57, 60, 65]. Reconstruction
following mastectomy was also higher in women resid-
ing in high SES areas [55, 57, 60]. This result was con-
sistent across finer scales of area SES analysis.
Post-treatment surgery
Fine scale area based SES was not associated with fur-
ther breast conserving or mastectomy surgery [62].
Treatment intensity before death
Women living in highly disadvantaged areas had a sig-
nificantly increased rate of hospitalisation in the last year
of life while having private health insurance was found
to be non-significant [61]. No significant differences
were shown in the second and third year prior to death.
Survival
Nine findings described the effect of SES on survival.
The majority of these used area level SES indicators with
two studies [66, 67] using individual and area level indi-
cators and one undertaking multilevel analysis [68].
Women in professional occupations [67, 68] and those
living in the most advantaged areas [68–72] had higher
survival. Two studies also reported this trend but reported
non-significance at the individual [66] and area level
[66, 73] after statistical attenuation. Non-significance
was also reported at the area level [67, 74]. However,
this result was apparent for 5-year unadjusted survival
estimates but changed for 10 year estimates where sur-
vival was lower for more women living in disadvantaged
areas [67].
Comparison of the scale of area analysis used showed
that the significant results found were based on coarser
scale of analysis. Non-significant relationships were
found at the finer scales. Comparison of differences in
area level definitions of SES at similar scales showed no
difference in the results found, for example, the com-
parison of IRSD to the index of education and occupa-
tion [70, 71] and the unemployment rate [74].
Mortality
Ten findings, the majority using area level indicators, ex-
amined the effect of SES on mortality. Conflicting results
were found at the individual level. Relative risk of mortal-
ity was higher (in descending order) for blue and white
collar and professional occupations when compared to
not in the labour forces [67] while a multilevel study
found that professionally employed woman had a higher
rate of mortality [75]. Alternatively, having private health
insurance had no relationship with mortality [58].
Mixed results were also found at the area level, with
five findings reporting negative associations indicating
that those living in the most disadvantaged areas had a
greater risk of dying following diagnosis of breast cancer
than those in less disadvantage areas [53, 58, 69–71].
However, four findings reported non-significant relation-
ships [47, 67], one of which was undertook multilevel
analysis [75] and one after statistical adjustment for de-
gree of spread of diagnosis [76]. These findings used
similar coarse levels of area scale for their analyses with
only one using a finer level of analysis [58]. One finding
with area scale not defined reported contradictory evi-
dence, with 10% higher mortality in women living in
high SES areas compared to those in low SES areas [77].
This study used a different definition of area based SES
than the IRSD which was more commonly used. Three
other findings also used different definitions showing
negative [70, 71] and also non-significant results [76].
Discussion
To illustrate the interrelatedness of the SES findings, a
feedback diagram (Fig. 2) is proposed. The diagram en-
ables us to contextualise the findings of this review as
interrelated components and elements within a larger,
complex system. The model consists of three compo-
nents: Component 1 represents the interaction of the
mammography, diagnosis and incidence elements, Com-
ponent 2 embodies the treatment interactions once
women have been diagnosed, and Component 3 signifies
survival and mortality relationships.
Component 1: mammography, diagnosis and incidence
The outcomes of Component 1 are diagnosis and inci-
dence, and the findings for Australia were similar to
international studies showing a higher cancer incidence
for women who live in high SES areas [9, 19] and a
greater likelihood of late stage diagnosis for more disad-
vantaged women [78, 79].
Figure 2 shows two potential paths from the popula-
tion to diagnosis with returning arrows from Screening
participation, Diagnostic investigation and Diagnostic re-
sults elements indicating no cancer diagnosed. The paths
illustrate either the choice to participate in the national
screening program (Loop 1) or the use of mammography
as a diagnostic tool for women who present with symp-
toms (Loop 2). Loop 2 can either relate to those women
who present with symptoms within the 2 year period be-
tween screenings or those who present with symptoms
and do not participate in screening. Internationally, the
higher participation of advantaged women in Loop 1
(screening) [5, 80] has been identified as a possible ex-
planation for the SES differences in diagnosis and
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incidence even in countries where financial barriers are
absent [81]. We found little evidence of this with never
having had a mammogram, participating in a recent
screening or being overdue for a screening having rela-
tively small associations between individual level SES.
However, there are a number of methodological issues
that should be considered. Firstly, the individual fallacy
bias may be apparent as the majority of studies are based
on individually defined SES (compositional) indicators.
This means that the contribution of area-based SES con-
textual factors have not been incorporated into the ma-
jority of the evidence base. Secondly, the study years
examined also varied with the majority of studies pub-
lished in the early – mid 2000’s. It is possible that the re-
sults of past literature do not reflect the current trends,
particularly since recent evidence has suggested that the
concerted effort to reach disadvantaged groups has been
effective [67]. Accessibility to screening facilities has also
been a factor in the equitable delivery of services. We
found only one year 2000 metropolitan based study [45]
that reported that low SES women had greater access to
mammographic screening. The lack of published re-
search of potential trends within Australia represents a
significant gap in our understanding of equitable service
provision, particularly as access is regularly cited as a
major barrier to influence participation [82].
Loop 2 reflects the underlying pattern of differences in
health and health service utilisation between women
with low and high SES characteristics. Evidence sug-
gests poorer health is experienced by those in lower
SES areas [83] leading to higher general practitioners
visits [84]. However, this increased visitation does not
lead to increased clinical surveillance for breast cancer
by asymptomatic referrals [56]. This may partially ex-
plain why our findings showed that incidence was lower
and stage of diagnosis was more advanced in women
with low SES. No studies included in this review exam-
ined the influence of SES on the early phase of cancer
investigation for women who present with symptoms
and use mammography as a diagnostic investigation
tool. Alternatively, the utilisation of medical specialists
more generally has been found to be higher in high SES
areas [85] after initial investigations have been carried
out. This difference in utilisation may point to why, we
found that incidence was higher but the stage of diag-
nosis was lower in high SES compared to low SES
women.
Relating the diagnosis outcome to the diagnostic pro-
cedures element through Loop 3 may also explain some
of the SES differences found in the choice of procedures
used. Here, the more advanced stage of cancer found in
women from low SES areas meant that the diagnostic
procedures administered were more invasive and certain
diagnoses results (triple negative result) were more
prevalent. Similar findings have been reported inter-
nationally [79, 86, 87].
Component 2: treatment choice
Australian treatment choice results were similar to inter-
national findings, with women living in deprived areas
having reduced odds of surgery and radiotherapy [86],
breast reconstruction surgery [88, 89] and higher rates
of non-conservative surgery [90] and mastectomies [86].
Fig. 2 illustrates within Component 2 that treatment
Fig. 2 Feedback diagram highlighting the interaction of elements along the breast cancer continuum both within and across the three components
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choice is a result of the interaction between patient and
provider characteristics which are presented as two re-
inforcing loops. Loop 4 highlights the interaction be-
tween provider characteristics such as type and quality
of care received and geographic location. Australia has a
vast land area, therefore geographic location is particu-
larly influential in terms of SES and equitable service
provision. For example, one national study [56] reported
that patients from lower SES areas were more likely to
live in more remote areas and as such were more likely
to be subject to the treatment choices available in re-
gional than major city hospitals. Additionally, in more re-
mote areas, there is a greater odds of receiving
treatment from lower caseload surgeons which has im-
plications for the choices made for initial patient man-
agement, treatment [91, 92] and outcomes [91, 93].
Loop 5 incorporates the outcome of treatment choice
which is predicated on the complex interaction between
the outcomes of Loop 4’s provider characteristics in
terms of what treatment choices are available and the
interaction with patient characteristics such as age and
the diagnosis inherited from Component 1 (Fig. 2). This
inheritance may explain SES differences in the treatment
choices undertaken. For surgery choices, we found that
mastectomies were more likely conducted in women
with low SES who were found with more advanced
stages of the disease. Alternatively, women with high
SES were more likely to have breast conserving surgery
possibly reflecting the less advanced stage of diagnosis,
or standard practice that tumours less than 20 mm in
diameter are treated with breast conserving surgery [94].
Patient characteristics incorporated into Loop 5 may
also explain SES differences across different stages of
treatment. For example, the most common initial
treatment for women with low SES and with early
stage cancer was no surgery rather than breast con-
serving therapy and ovarian ablation procedures. Fur-
thermore, those women with low SES and receiving
end stage treatments were less likely to have post-
operative radiotherapy and breast reconstruction sur-
gery. Some possible explanations for the choice for less
conservative treatments may reflect their difficulty in
weighing up a range of potential options and side ef-
fects because of their lower education levels. Addition-
ally, the potential additional indirect costs and
disruptions to family and work life associated with
additional treatments may also be unpalatable espe-
cially to those on lower incomes or in certain types of
employment.
One major limitation in the Component 2 subsystem
is that the initial establishment of association between
geographic location (remoteness) and SES has had lim-
ited exploration specifically in relation to women diag-
nosed with breast cancer. Apart from the national study
advocating SES differences in remote areas, two state
based studies using the same cancer registry reported no
association between remoteness and SES [54, 68]. Our
review also identified several other papers [59, 73] that
focussed on hospital factors and remoteness as key influ-
encers of outcomes but none investigated remoteness as
a relationship with SES. The small evidence base and
conflicting results demonstrates a much needed future
direction to investigate if SES gradients exist across each
region’s urban, rural and remoteness classification [54]
in reference to the treatments chosen.
No studies were found on the relationships between
SES and surgical outcomes, post-surgical complications,
length of stay and waiting times in diagnosis and treat-
ment stages which are used as surrogates for the quality
of treatment received. These issues have been reported
internationally [3, 86, 95] and need to be explored
further.
Component 3: survival or mortality
Component 3’s elements of survival and mortality repre-
sent the outcomes from the treatment choice undertaken
in Component 2. Two feedback loops are proposed, Loop
6 which represents a movement of a women, surviving
cancer, back to the population. Loop 7 represents a path to
diagnostic investigation for recurrences. Non-significant
relationships for individual (after adjustment) or area level
SES relationships were reported for distant recurrences
[49] while no evidence was available for SES relationships
with other recurrences.
Survival and mortality elements combined with Com-
ponent 1’s element of incidence are essential population
based indicators for public health and cancer control
[96]. Just over half the findings reported higher rates of
survival for women in high SES areas with others
reporting non-significance. Less evidence of an SES
gradient was found for mortality, with six findings
reporting negative relationships, four reporting non-
significant associations and two positive relationships.
Similar findings have been reported internationally for
survival [79, 97–99] and mortality [4, 19]. Interactions
within the components of the model may suggest a
greater influence of SES than the current evidence sug-
gests. For example, with a higher incidence of small
localised breast tumours in women with high SES we
may expect a greater likelihood of survival and less
mortality while a lower incidence of more advanced
stage of cancer in low SES women should point to a
lesser likelihood of survival and greater mortality.
However, this isn’t supported by the survival and
mortality literature. It is possible that the influence of
SES across the components is moderated by the
choice of treatments in Component 2 which in one
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study was found, in general, to be similar across the
SES gradient [56]. Additionally, even with different
types of surgery which was also predicated by SES i.e.
breast conserving surgery versus mastectomy, survival
has been shown to be similar across different diagno-
sis stages [100, 101].
Methodological issues and limitations
This review focused on Australian women as the target
population, which includes some women with Indigenous
heritage and other ethnicities as part of the general popu-
lation, however, our exclusion of papers that focused only
on this population, may have influenced our findings. In-
digenous women living in Australia are more likely to be
of lower SES, have greater remoteness, and experience
worse outcomes at all stages of the cancer trajectory than
women of non-Indigenous heritage [102]. Across the
breast cancer continuum, comparison of Indigenous to
non-Indigenous women have found that they are more
likely to be disadvantaged [103], are less likely to partici-
pate in breast cancer screening and rescreening [104],
have more advanced stages of diagnosis and more likely to
die prematurely [103–105]. Interestingly, the evidence for
uptake of treatment is mixed. One study finding has re-
ported no difference in treatment patterns [103] while an-
other found Indigenous women were less likely to receive
surgical treatment [105]. When surgery was undertaken
the choice of treatment also differed with mastectomy a
more common procedure than complete local excision
[104]. While Indigenous women make up a small propor-
tion of the total Australian population, they experience
poorer cancer outcomes. Future research needs to im-
prove our understanding of this inequity across the cancer
continuum.
Across the range of studies we found that issues of in-
dicator type and composition, and to a lesser extent the
modifiable areal unit problem (MAUP), were not signifi-
cant across the majority of evidence. For indicator types
and composition, this result was more to do with the
fact that the majority of studies used the Index of Rela-
tive Socio-economic Disadvantage (IRSD) to represent
area level SES. Where studies used different measures,
they were usually based on income, education or occu-
pation and produced similar relationships to using the
IRSD. This suggests that differences in the selection and
composition of indicators were not an issue in result dif-
ferences. We did find small evidence for the MAUP in
the evidence gleaned for survival where results at the
fine scale were non-significant compared to positive as-
sociations found at coarser scales. However, a recent
study [106] has provided statistical evidence that
changes in scales of analysis showed little difference in
survival rates.
This study may have potential limitations that bias
the evidence reported through the databases which
were searched and the exclusion of the grey literature.
Inclusion of the grey literature may have provided
more evidence as our restriction to peer-reviewed
studies are more likely to report significant findings.
The evidence shown in this study does have a publica-
tion bias, with over a third of the evidence obtained
coming from studies investigating the New South
Wales’ population, 32% of the Australian population.
This bias was significant in the survival and mortality
evidence base where studies from this geographic area
made up the majority of results. Given the small num-
ber studies for some stages across the continuum the
strength and direction of the relationships reported
needs to be interpreted with caution. Further, a longi-
tudinal view of the SES gradients experienced by
women across the continuum is needed. While the
number of studies found in each stage is a limitation it
also represents areas where more research should be
undertaken to create a larger sample size ideally across
other geographic areas thus decreasing the publication
bias found.
There was a lack of multilevel analysis studies, with
only three found across the continuum. Our evidence
does suffer from the methodological issues of individual
fallacy for screening studies and ecological fallacy in
other outcomes along the continuum. Given that the
results of the three multilevel studies corroborated with
the results found in other studies i.e. in the issues of
diagnosis [54], survival [68] and mortality [75], we can
have some confidence in the evidence base derived
from the alternative study designs. Undertaking multi-
level analysis in the area of screening provides the
easiest opportunity as individual level data is already
collected and application of area level SES is quite arbi-
trary if residential location is available. These types of
studies are key to understanding the strength of the
compositional (individual) or contextual (area) effects of
SES providing evidence for what type of interventions can
be applied. This evidence can inform policy decisions with
individual level SES factors driving changes to broad
policies at the population level. Evidence of area level SES
interactions could mean a more targeted approach to re-
source allocation [107], applying different strategies for
the same groups in different areas [108] or the allocation
of resources across multiple levels [109] of the continuum.
We found disparities along the continuum. Our feed-
back diagram provides a way to summarise the evidence
base and examine relationships within a wider integrated
framework. Considering the associated economic costs
in future research will help quantify the impacts on
quality of life for people and their families, the health
care system and society.
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Conclusion
In a universal health system such as that in Australia,
evidence of an SES gradient exists, however, the strength
and direction of this relationship varies along the breast
cancer continuum. This is a complex relationship and
the heterogeneity in study design, the SES indicator se-
lected and the scale they represent further complicates
our understanding of its influence. More complex multi-
level studies are needed to better understand these rela-
tionships, the interactions between predictors and to
reduce biases introduced by methodological issues.
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